Evidence map›Paper›PMID 22693038›Full record

SynthesisPediatric blood & cancer2013

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.

Sue Richards, Ching-Hon Pui, Paul Gayon, Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG)

Erratum issuedAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pediatric blood & cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.Current hematologic malignancy reports · 2022
    Review
  17. Lymphoblastic Lymphoma: a Concise Review.Current oncology reports · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
    Attarbarschi, A [corrected to Attarbaschi, A]; Escheriche, G [corrected to Escherich, G]
5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sue RichardsUniversity of Oxford, Oxford, UK. sue.richards@ctsu.ox.ac.uk
Ching-Hon Pui
Paul Gayon
Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG)
Children's Hospital of Los Angeles · USSt. Jude Children's Research Hospital · USUniversity of Oxford · GB

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Medical Research Council G0901530Medical Research Council MC_U137686856NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Treatment of the central nervous system (CNS) is an essential therapy component for childhood acute lymphoblastic leukemia (ALL). Individual patient data from 47 trials addressing 16 CNS treatment comparisons were analyzed. Event-free survival (EFS) was similar for radiotherapy versus intrathecal (IT), and radiotherapy plus IT versus IV methotrexate (IV MTX) plus IT. Triple intrathecal therapy (TIT) gave similar EFS but poorer survival than intrathecal methotrexate (IT MTX), but additional IV MTX improved both outcomes. One trial resulted in similar EFS and survival with IV MTX plus IT MTX versus TIT alone. Radiotherapy can generally be replaced by IT therapy. TIT should be used with effective systemic therapy such as IV MTX.

Indexed as

Randomized Controlled Trials as TopicAntineoplastic AgentsCentral Nervous SystemCentral Nervous System NeoplasmsChildHumansInjections, SpinalPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents

Identifiers

PMID22693038
PMCPMC3461084
OpenAlexW2000712817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.